Quotes OSE Immunotherapeutics Deutsche Boerse AG
Stocks
6OP
FR0012127173
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:02:47 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 3.156 EUR | +0.96% |
|
-3.55% | -39.77% |
| 08-19 | Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine | RE |
| 06-11 | OSE Immunotherapeutics Recovers Following Oddo BHF Endorsement |
Stock exchange
Deutsche Boerse AG
6OP 3.156 €
+0.96%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| OSE | 3.196EUR | -0.62% | 223K € | ||
Börse Stuttgart
| 6OP | 3.170EUR | -0.81% | 7.45K € | |
Tradegate
| 6OP | 3.184EUR | -0.81% | 2.48K € | |
CBOE
| OSEp | 3.190EUR | -0.25% | 2.48K € | |
Deutsche Boerse AG
| 6OP | 3.156EUR | +0.96% | 0 € | |
CBOE
| 0RAD | 3.411EUR | 0.00% | 0 € | |
Boerse Muenchen
| 6OP | 3.206EUR | -0.68% | 0 € |
Quotes 5-day view: OSE Immunotherapeutics
Delayed Quote Deutsche Boerse AG| 2026-08-26 | 2026-08-27 | 2026-08-28 | 2026-08-31 | 2026-09-01 | |
|---|---|---|---|---|---|
| Last | €3.156 | €3.164 | €3.172 | €3.126 | €3.156 |
| Change | +0.57% | +0.25% | +0.25% | -1.45% | +0.96% |
Performance
| 1 day | +0.96% | ||
| 1 week | -3.55% | ||
| Current month | +0.96% | ||
| 1 month | -0.25% | ||
| 3 months | -33.95% | ||
| 6 months | -29.36% | ||
| Current year | -39.77% | ||
| 1 year | -48.35% | ||
| 3 years | +14.56% | ||
| 5 years | -73.83% | ||
| 10 years | -50.27% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
75,785,923
Market Cap (USD)
87,851,800
Net sales (EUR)
2,619,000
Net sales (USD)
3,035,971
Number of employees
64
Sales / Employee (EUR)
40,922
Sales / Employee (USD)
47,437
Free-Float
78.15 %
Free-Float capitalization (EUR)
56,562,441
Free-Float capitalization (USD)
65,567,748
Indicators
Moving average 5 days
3.151
Moving average 20 days
3.221
Moving average 50 days
3.215
Moving average 100 days
3.597
Price spread / (MMA5)
-0.15%
Price spread / (MMA20)
+2.05%
Price spread / (MMA50)
+1.86%
Price spread / (MMA100)
+13.96%
STIM
RSI 9 days
43.21
RSI 14 days
45.31
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.96% | -3.55% | -48.35% | +14.56% | 87.85M | ||
| +0.21% | -1.70% | +1.90% | +18.18% | 49.81B | ||
| +2.09% | -0.81% | +452.73% | +517.81% | 44.06B | ||
| -1.09% | -0.73% | +35.40% | +16.04% | 42.99B | ||
| -0.26% | -3.58% | +17.19% | +72.80% | 40.88B | ||
| -0.48% | -3.09% | +17.78% | +49.80% | 33.11B | ||
| -1.81% | -5.94% | +22.65% | +115.79% | 16.58B | ||
| -1.06% | +3.29% | - | - | 17.27B | ||
| -1.35% | -2.32% | +10.40% | +25.90% | 14.63B | ||
| -2.05% | -5.44% | +72.89% | +36.51% | 13.76B | ||
| Average | -0.63% | -1.64% | +64.73% | +96.38% | 27.32B | |
| Weighted average by Cap. | -0.48% | -1.79% | +95.27% | +124.41% |
Historical Quotes: OSE Immunotherapeutics
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 3.13 | 3.17 | |
| 1 month | 3.11 | 3.32 | |
| Current year | 2.86 | 5.57 | |
| 1 year | 2.86 | 7.16 | |
| 3 years | 2.86 | 10.68 | |
| 5 years | 2.7 | 13.5 | |
| 10 years | 2.7 | 15.5 |
Monthly variations
Annual variations
| 2026 | -39.77% | ||
| 2025 | -27.32% | ||
| 2024 | +68.46% | ||
| 2023 | -35.00% | ||
| 2022 | -36.19% | ||
| 2021 | +49.57% | ||
| 2020 | +90.61% | ||
| 2019 | +11.04% | ||
| 2018 | -11.80% | ||
| 2017 | -46.47% | ||
| 2016 | -17.65% | ||
| 2015 | -15.90% |
- Stock Market
- Stocks
- OSE Stock
- 6OP Stock
- Quotes OSE Immunotherapeutics
Select your edition
All financial news and data tailored to specific country editions

















